A new clinical study recently conducted by the National Institutes of Health (NIH) describes the immune response triggered by COVID-19 infection that damages the brain’s blood vessels and may lead to short- and long-term neurological symptoms.
Published in the peer-review journal Brain on July 5, 2022, researchers examined brain changes in nine people who died suddenly after contracting the SARS-CoV-2 coronavirus.
Can COVID-19 Brain-Fog Be Prevented
Severe COVID-19 Rates Low With Monoclonal Antibody Therapy During Delta Surge
Rates of severe disease low for high-risk patients with mild-to-moderate COVID-19 treated with antispike monoclonal antibodies
COVID-19 Vaccination Greatly Reduced Morbidity, Mortality Burden in U.S.
Vaccination estimated to have prevented 52, 56, and 58 percent of expected infections, hospitalizations, deaths in adults from Sept. 1 to 30, 2021